Urgent

Chemotherapy hypersensitivity reaction (platinum/taxane)

Infusion reactions and anaphylaxis to cytotoxic agents · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Taxanes typically cause first-dose infusion reactions within minutes (facial flushing, back pain, dyspnoea) driven by non-IgE mechanisms, whereas platinum agents cause IgE-mediated reactions after several cycles of sensitisation. Recognising the pattern directs premedication, rate adjustment, or desensitisation when the drug is essential.

Red flags

  • Hypotension, wheeze or airway swelling
  • Severe back/chest/pelvic pain during infusion
  • Reaction recurring despite premedication
  • Platinum reaction after multiple cycles (IgE sensitisation)
  • Oxygen desaturation

Assessment

Differential diagnosis

  • Taxane infusion reaction (first/second dose, non-IgE)
  • Platinum IgE-mediated hypersensitivity (after multiple cycles)
  • Cytokine-release reaction to monoclonal agents
  • Vehicle reaction (Cremophor/polysorbate)
  • Anxiety or vasovagal reaction

Investigations

  • Document timing relative to infusion start and cycle number
  • Continuous monitoring during infusion
  • Mast cell tryptase after significant reactions
  • Skin testing to the platinum agent to confirm IgE sensitisation
  • Pre-infusion observations and symptom grading (CTCAE)

Management

  • Stop the infusion immediately at the first sign of a reaction
  • Assess severity: treat airway/cardiovascular compromise as anaphylaxis with IM adrenaline
  • Give oxygen, IV fluids and antihistamine; add corticosteroid
  • For mild taxane reactions, once settled, restart at a slower rate with enhanced premedication
  • For platinum reactions, perform skin testing and plan formal desensitisation if the drug is essential
  • Ensure robust premedication (corticosteroid, H1 and H2 antihistamine) before future cycles
  • Involve oncology and allergy to decide between rechallenge, desensitisation or alternative agent
  • Document the reaction grade and mechanism clearly in the chemotherapy record

Drugs & doses

Adrenaline IM — 500 mcg (0.5 mL 1:1000) for anaphylaxis
Chlorphenamine — 10 mg IV/IM for cutaneous/systemic reactions
Hydrocortisone — 200 mg IV for moderate-severe reactions
Dexamethasone — 20 mg IV/oral as premedication before taxanes
Ranitidine alternative H2 blocker (famotidine 20 mg IV) — as premedication adjunct
Salbutamol — 5 mg nebulised for bronchospasm

Disposition

Observe after mild reactions and continue with enhanced premedication; refer significant platinum reactions to allergy for skin testing and desensitisation planning.

Complications & pitfalls

  • Anaphylaxis and cardiovascular collapse
  • Interruption of essential cancer treatment
  • Breakthrough reactions during desensitisation
  • Progressive severity with repeated platinum exposure
  • Delay to oncology regimen

Exam pearls

  • Taxane reactions occur on first/second exposure and are usually rate-related; platinum reactions need prior sensitisation
  • Robust corticosteroid and antihistamine premedication prevents most taxane reactions
  • Skin testing predicts platinum hypersensitivity and guides desensitisation
  • Desensitisation allows continued use of an essential agent in a monitored setting

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.